1. Fisher ES, Baron JA, Malenka DJ, et al. Hip fracture incidence and mortality in New England. Epidemiology. 2:116-22 (1991)

2. Creasman, W. T., Henderson, D., Hinshaw, W., and Clarke-Pearson, D. L. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet. Gynecol. 67: 326-330 (1986).

3. Lee, R. B., Burke, T. W., Park, R. C. Estogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol. Oncol. 36: 189-194 (1990).

4. American College of Obstetricians and Gynecologists, Committee on Gynecologic Practice. Estrogen replacement therapy and endometrial cancer. ACOG Committee Opinion No. 126. Washington DC: American College of Obstetricians and Gynecologists (1993).

5. DiSaia, P.J., Creasman, W.T., Boronow, R.C., and Blessing, J.A. Risk factors and recurrent patterns in Stage I endometrial cancer. Am. J. Obstet. Gynecol.. 151: 1009-1015 (1985).

6. Creasman, W.T., Morrow, C. P., Bundy, B.N., Homesley, H.D., Graham, J.E., Heller, P.B. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group Study. Cancer. 60: 2035-2041 (1987).